Topiramate-induced palinopsia: A case series and review of the literature

Samuel H. Yun, Patrick J. Lavin, Martha P. Schatz, Robert L. Lesser

Producción científica: Articlerevisión exhaustiva

21 Citas (Scopus)


Background: To report palinopsia as a possible side effect of topiramate. Methods: Case series and review of the literature. Results: Nine patients in our series, and 4 previously reported patients, who developed palinopsia while on topiramate, are reviewed. All patients were women, and comorbidities included migraine, idiopathic intracranial hypertension, and bulimia nervosa. Palinopsia resolved in 8 patients after stopping or decreasing the dose of topiramate. The lowest dose of topiramate causing palinopsia was 25 mg twice a day. More than half of our patients reported exacerbation of visual disturbance in early morning or late evening. Conclusions: Topiramate-induced palinopsia may be underdiagnosed because physicians do not inquire about such visual symptoms.

Idioma originalEnglish (US)
Páginas (desde-hasta)148-151
Número de páginas4
PublicaciónJournal of Neuro-Ophthalmology
EstadoPublished - jun 30 2015

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology


Profundice en los temas de investigación de 'Topiramate-induced palinopsia: A case series and review of the literature'. En conjunto forman una huella única.

Citar esto